references | Country | Year | Sample Size | Study Design | Quality Assessment Criteria | Positive cases | OR Age > 30 | Low CI Age > 30 | High CI Age > 30 | OR Female | Low CI Female | High CI Female | OR High school | Low CI High school | High CI High school | OR Unprotected sex | Low CI Unprotected sex | High CI Unprotected sex | OR Duration of injecting drug use | Low CI Duration of injecting drug use | High CI Duration of injecting drug use | OR Past treatment attempt | Low CI Past treatment attempt | High CI Past treatment attempt | OR Previous testing | Low CI Previous testing | High CI Previous testing |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
[32] | USA | 2012 | 533 | Cross-section | Good | 469 | Â | Â | Â | Â | Â | Â | 1.9 | 1.4 | 2.5 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
[33] | India | 2015–2016 | 1241 | Cross-section | Very Good | 298 |  |  |  |  |  |  | 3.5 | 1.2 | 10.4 | 0.5 | 0.3 | 0.9 | 2.1 | 1 | 4.2 |  |  |  |  |  |  |
[34] | Greece | 2013–2015 | 2747 | Cross-section | Very Good | 2294 | 2.6 | 1.6 | 4.3 |  |  |  |  |  |  |  |  |  | 3 | 2 | 4.5 | 3.6 | 2.6 | 4.8 |  |  |  |
[35] | Australia | 2016–2018 | 565 | Cohort | Very Good | 367 |  |  |  | 1.92 | 1.11 | 3.3 |  |  |  |  |  |  |  |  |  |  |  |  | 2.15 | 0.97 | 4.8 |
[36] | Australia | 2007 | 888 | Cross-section | Good | 826 | Â | Â | Â | Â | Â | Â | 0.36 | 0.18 | 0.81 | Â | Â | Â | Â | Â | Â | 2.78 | 1.48 | 5.2 | Â | Â | Â |
[37] | Thailand | 2011 | 427 | Cross-section | Very Good | 141 | Â | Â | Â | Â | Â | Â | 2.2 | 1.35 | 3.64 | 0.62 | 0.32 | 0.97 | Â | Â | Â | 3.47 | 1.85 | 6.95 | Â | Â | Â |
[38] | Ukraine | 2014–2015 | 1613 | Cross-section | Satisfactory | 348 |  |  |  | 1.61 | 1.08 | 2.41 |  |  |  |  |  |  | 0.98 | 0.96 | 1 | 2.24 | 1.32 | 3.81 |  |  |  |
[39] | Australia | 215 | 1173 | Cross-section | Good | 633 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 2.15 | 1.149 | 3.87 | 2 | 1.31 | 3.06 |
[40] | Germany | 2020 | 2059 | Cross-section | Satisfactory | 1503 | 2.2 | 1.2 | 4.2 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
[41] | India | 2013–2017 | 11,993 | Cross-section | Good |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1.72 | 1.22 | 2.43 |  |  |  |
[42] | USA | 2012–2013 | 129 | Cross-section | Good | 107 | 4.2 | 1.7 | 7.5 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
[43] | Spain | 2011 | 240 | Cross-section | Very Good | 179 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
[42] | USA | 2012–2013 | 129 | Cross-section | Very Good | 107 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
[44] | USA | 2015 | 14,253 | Cross-section | Good | 157 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
[45] | Canada | 2012–2013 | 663 | Cross-section | Satisfactory | 564 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
[46] | USA | 2003–2004 | 217 | Cross-section | Good | 100 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
[47] | UK | 2012–2015 | 211 | Cross-section | Very good | 135 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
[41] | India | 2013–2017 | 11,993 | Cross-section | Good | 469 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |